Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial

Company expect to file regulatory submissions in 2021

Pharma’s reputation has climbed during COVID-19 pandemic, study finds

Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

Health service extends access to at-home treatments to reduce patients’ risk of contracting coronavirus

Updated Date: Tue, 28 Jul 2020 00:00:00 EDT

Updated Date: Tue, 28 Jul 2020 00:00:00 EDT

A drug candidate previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse […]

I was both excited and disappointed to read Cylus and Smith’s article on the economy of wellbeing:1 excited […]

bmj;370/aug04_5/m3039/FAF1faStella Elizabeth Grace Gibson was born in Paisley, Renfrewshire, in 1927 to William Hamilton Gibson, a GP, and […]

Novartis eyes 3rd Kymriah indication with follicular lymphoma trial win aliu Tue, 08/04/2020 – 11:48